Golden State Warriors star Steph Curry is set to sign a lifetime contract with sportswear brand Under Armour that could be worth over US$1 billion.
Curry and Under Armour teamed for the first time in 2013, and his current reputed US$20 million per year contract with the Baltimore-based company is scheduled to expire in 2024.
In 2020, the four-time NBA champion and Under Armour launched Curry Brand, a dedicated apparel division designed to draw younger consumers.
Only legends Michael Jordan and Lebron James have received lifetime contracts in the NBA; James inked a lifetime contract with Nike in 2015 that is estimated to be worth more than US$1 billion.
Soccer legends Lionel Messi and Cristiano Ronaldo have lifetime deals with Nike and Adidas, respectively. While Messi's contract, inked in 2017, is unknown, Ronaldo's Nike pact, signed in 2016, is reputedly worth US$1 billion.


Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Apple Eyes U.S. Formula 1 Broadcast Rights in Major Sports Streaming Push
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient
From Messi to Mika Häkkinen: how top athletes can slow down time
Instagram Outage Disrupts Thousands of U.S. Users
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Native American Groups Slam Trump’s Call to Restore Redskins Name
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
JD Vance to Lead U.S. Presidential Delegation at Milano Cortina Winter Olympics Opening Ceremony
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Threatens Stadium Deal Over Washington Commanders Name
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



